Is the Articular Cartilage Regeneration Approachable Through Mesenchymal Stem Cells Therapies?

Today great hope is set on regenerative medicine in all medical fields. Leland Kaiser introduced the term “Regenerative Medicine” in 1992. He forecasted that a “new branch of medicine will develop that attempts to change the course of chronic diseases and in many instances will regenerate tired and...

Descripción completa

Detalles Bibliográficos
Autores: Lopez Puerta, José María, Zamora-Navas, Plácido, Claros, Silvia, Rico-Llanos, Gustavo A., Avedillo, Inés, Andrades, José A., Becerra, José, Andrades, José A. (Coordinador)
Tipo de recurso: capítulo de libro
Estado:Versión publicada
Fecha de publicación:2013
País:España
Institución:Universidad de Sevilla (US)
Repositorio:idUS. Depósito de Investigación de la Universidad de Sevilla
OAI Identifier:oai:idus.us.es:11441/182685
Acceso en línea:https://hdl.handle.net/11441/182685
https://doi.org/10.5772/56298
Access Level:acceso abierto
Palabra clave:Bone-Marrow
Chondral
Defects
Knee
Microfracture
Chondrogenesis
Transplantation
Lubricin
Chodrocytes
Repair
Descripción
Sumario:Today great hope is set on regenerative medicine in all medical fields. Leland Kaiser introduced the term “Regenerative Medicine” in 1992. He forecasted that a “new branch of medicine will develop that attempts to change the course of chronic diseases and in many instances will regenerate tired and failing organ systems” (Kaiser, 1992). Since then, scientists all over the world try to develop cell-based approaches to regenerate damaged tissues, or even substitute whole organs (Ehnert et al., 2009). Degenerative disease of articular cartilage (AC), generically known as osteoarthritis (OA), is an irreversible evolution process towards terminal articular failure. Due to its high prevalence on population and its socioeconomic impact, this condition is of great concern, and this way more resources and effort are dedicated to the research on its development. Cartilage tissue engineering seeks to combine cells, biomaterial scaffolds, and bioactive signals to create functional tissue replacements to treat cartilage injuries or osteoarthritis (Song et al., 2004). Cartilage degenerative disease, OA, is the end stage of several conditions such as trauma, inflammatory diseases, overweight etc. The fatalistic theory that states that it is impossible to recover the cartilage once it has been damaged leads to the assumption that the progression to any form of OA is unavoidable (Fig. 1). The annual incidence of young adults suffering any cartilage injury in UK is 10000 and this figure is continuously increasing (NICE, 2008).